FLUORINATION PROCESS OF ANILIDE DERIVATIVES AND BENZOTHIAZOLE FLUORINATE DERIVATIVES AS IN VIVO IMAGING AGENTS

The invention relates to a process for preparation of a compound of formula (I): R1 is selected from C1-6alkyl, C2-6alkenyl, and C2-6alkynyl ; which comprises: (i) reaction with fluoride, suitably [18F]fluoride, of a corresponding compound of formula (II): wherein R2 is selected from hydrogen, C1-10...

Full description

Saved in:
Bibliographic Details
Main Authors Steven Michael FAIRWAY, Nicolas LASBISTES, Lorenzo WILLIAMS, Clare Louise JONES, Bengt LANGSTROM, Farhad KARIMI, Anthony Eamon STOREY, Alexander Mark GIBSON, Robert James NAIRNE, Denis Raymond Christophe BOUVET
Format Patent
LanguageEnglish
Spanish
Published 10.08.2016
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The invention relates to a process for preparation of a compound of formula (I): R1 is selected from C1-6alkyl, C2-6alkenyl, and C2-6alkynyl ; which comprises: (i) reaction with fluoride, suitably [18F]fluoride, of a corresponding compound of formula (II): wherein R2 is selected from hydrogen, C1-10alkyl, C1-10haloalkyl, C6-14aryl,C6-14arylalkyl, -(CH2CH2O)q-CH3wher ein q is an integer of from 1 to 10; R1 is as defined for the compound of formula (I); and R3 is a leaving group. Certain novel precursors of formula (II) and radiopharmaceutical kits containing such precursors are also claimed. La presente invención se refiere a un proceso para la preparación de un compuesto de la fórmula (I): R1 es seleccionado de C1-6alquilo, C2-6alquenilo y C2-6alquinilo; el cual comprende (I) la reacción con fluoruro, en forma adecuada [18F]fluoruro, de un compuesto correspondiente de la fórmula (II): en donde R2 es seleccionado de hidrógeno, C1-10alquilo, C1 10haloalquilo, C6-14arilo, C6-14arilalquilo, (CH2CH2O)qCH3 en donde q es un entero de 1 a 10; R1 es tal como se define para el compuesto de la fórmula (I); y R3 es un grupo de partida. También se reivindican ciertos precursores novedosos de la fórmula (II) y equipos radiofarmacéuticos que contienen dichos precursores.
Bibliography:Application Number: MX20130013741